Factors associated with treatment outcome of MDR/RR-TB patients treated with shorter injectable based regimen in West Java Indonesia

BACKGROUND AND AIMS: Multi drug or rifampicin resistant tuberculosis (MDR/RR-TB) is a major burden to TB prevention and eradication globally. Since 2016, WHO guidelines have included options for treating MDR/RR-TB with a standard regimen of 9 to 11 months duration (the ’shorter regimen’) rather than...

Descripción completa

Detalles Bibliográficos
Autores principales: Soeroto, Arto Yuwono, Nurhayati, Raden Desy, Purwiga, Aga, Lestari, Bony Wiem, Pratiwi, Chica, Santoso, Prayudi, Kulsum, Iceu Dimas, Suryadinata, Hendarsyah, Ferdian, Ferdy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797248/
https://www.ncbi.nlm.nih.gov/pubmed/35089981
http://dx.doi.org/10.1371/journal.pone.0263304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797248/
https://www.ncbi.nlm.nih.gov/pubmed/35089981
http://dx.doi.org/10.1371/journal.pone.0263304

Ejemplares similares